These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


248 related items for PubMed ID: 18713990

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.
    Lai C, August S, Albibas A, Behar R, Cho SY, Polak ME, Theaker J, MacLeod AS, French RR, Glennie MJ, Al-Shamkhani A, Healy E.
    Clin Cancer Res; 2016 Aug 15; 22(16):4236-48. PubMed ID: 27034329
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. OX40 is required for regulatory T cell-mediated control of colitis.
    Griseri T, Asquith M, Thompson C, Powrie F.
    J Exp Med; 2010 Apr 12; 207(4):699-709. PubMed ID: 20368580
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. OX40 Costimulation Inhibits Foxp3 Expression and Treg Induction via BATF3-Dependent and Independent Mechanisms.
    Zhang X, Xiao X, Lan P, Li J, Dou Y, Chen W, Ishii N, Chen S, Xia B, Chen K, Taparowsky E, Li XC.
    Cell Rep; 2018 Jul 17; 24(3):607-618. PubMed ID: 30021159
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. PKC-ѳ is dispensable for OX40L-induced TCR-independent Treg proliferation but contributes by enabling IL-2 production from effector T-cells.
    Alharshawi K, Marinelarena A, Kumar P, El-Sayed O, Bhattacharya P, Sun Z, Epstein AL, Maker AV, Prabhakar BS.
    Sci Rep; 2017 Jul 26; 7(1):6594. PubMed ID: 28747670
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The role of OX40-mediated co-stimulation in T-cell activation and survival.
    Redmond WL, Ruby CE, Weinberg AD.
    Crit Rev Immunol; 2009 Jul 26; 29(3):187-201. PubMed ID: 19538134
    [Abstract] [Full Text] [Related]

  • 19. OX40, OX40L and Autoimmunity: a Comprehensive Review.
    Webb GJ, Hirschfield GM, Lane PJ.
    Clin Rev Allergy Immunol; 2016 Jun 26; 50(3):312-32. PubMed ID: 26215166
    [Abstract] [Full Text] [Related]

  • 20. CD134/CD137 dual costimulation-elicited IFN-γ maximizes effector T-cell function but limits Treg expansion.
    St Rose MC, Taylor RA, Bandyopadhyay S, Qui HZ, Hagymasi AT, Vella AT, Adler AJ.
    Immunol Cell Biol; 2013 Feb 26; 91(2):173-83. PubMed ID: 23295363
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.